Listed

IGC Pharma, Inc.: Form 10-KT, filed Mar 18, 2026

Filed with the SEC on Mar 18, 2026 and accepted by EDGAR at Mar 18, 2026, 16:02 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue9 months2025-04-01 to 2025-12-31$869.0kus-gaap:Revenues
Cost of revenue9 months2025-04-01 to 2025-12-31$572.0kus-gaap:CostOfRevenue
Gross profit9 months2025-04-01 to 2025-12-31$297.0kus-gaap:GrossProfit
Research and development9 months2025-04-01 to 2025-12-31$3.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative9 months2025-04-01 to 2025-12-31$4.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income9 months2025-04-01 to 2025-12-31−$7.7mus-gaap:OperatingIncomeLoss
Income tax9 months2025-04-01 to 2025-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income9 months2025-04-01 to 2025-12-31−$4.1mus-gaap:NetIncomeLoss
Diluted EPS9 months2025-04-01 to 2025-12-31−$0.05us-gaap:EarningsPerShareDiluted
Basic EPS9 months2025-04-01 to 2025-12-31−$0.05us-gaap:EarningsPerShareBasic
Diluted shares (weighted)9 months2025-04-01 to 2025-12-3188,851,556 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2025-04-01 to 2025-12-31−$4.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2025-04-01 to 2025-12-31$49.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2025-12-31$900.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-12-31$1.8mus-gaap:AssetsCurrent
Total assetsAt period end2025-12-31$9.7mus-gaap:Assets
Current liabilitiesAt period end2025-12-31$2.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-12-31$2.3mus-gaap:Liabilities
Long-term debtAt period end2025-12-31$131.0kus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2025-12-31$3.0kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2025-12-31$7.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-26-000941. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.